Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Journal for Immunotherapy of Cancer|June 28, 2022
Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockadeWon Suk Lee, Dong Sung Kim, Jeong Hun Kim, et al.
JHEP Reports : Innovation in Hepatology|March 3, 2023
High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinomaHannah Yang, Beodeul Kang, Yeonjung Ha, et al.
Plos One|March 26, 2019
Early experience with Watson for oncology in Korean patients with colorectal cancerEui Joo Kim, Hyun Sun Woo, Jae Hee Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2018
Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint BlockadeHong Jae Chon, Won Suk Lee, Hannah Yang, et al.
Journal of Clinical Gastroenterology|April 29, 2008
Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasisWon-Suk Lee, Seong Hyeon Yun, Ho-Kyung Chun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal CancersSung-Yup Cho, Jeesoo Chae, Deukchae Na, et al.
Cancer Medicine|June 9, 2025
Organ-Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective StudyJung Sun Kim, Youngun Kim, Beodeul Kang, et al.
Surgical Endoscopy|July 14, 2018
Autologous blood, a novel agent for preoperative colonic localization: a safety and efficacy comparison studyEui Joo Kim, Jun-Won Chung, Su Young Kim, et al.
Oncogene|April 13, 2021
CRISPR screens identify a novel combination treatment targeting BCL-X<sub>L</sub> and WNT signaling for KRAS/BRAF-mutated colorectal cancersHae Rim Jung, Yumi Oh, Deukchae Na, et al.
JHEP Reports : Innovation in Hepatology|March 2, 2026
Plasma GPC3 reflects tumor GPC3 expression and predicts clinical outcomes in advanced HCC treated with atezolizumab + bevacizumabDong Jun Shin, Sohyun Hwang, Beodeul Kang, et al.
Pageof 20